Symbol: |
FANCL
|
Description: |
Fanconi anemia, complementation group L [Source:HGNC Symbol;Acc:20748]
|
Location: |
Chr2:58386378-58468507[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:191
Gene |
Compound |
Gen_sig |
Exp_pattern |
FANCL |
NSC 720616 |
0.036 |
Down |
FANCL |
6,7-dimethyl-1,4-di-N-oxide-3-methylquinoxalin-2-yl-4-(4-nit rophenyl)piperazinyl ketone |
0.034 |
Up |
FANCL |
NSC 723378 |
0.049 |
Down |
FANCL |
Pyridone-OCH3 |
0.044 |
Up |
FANCL |
(Thiopen-2-ylmethylene-hydrazinocarbonylmethylsulfanyl) acetic acid(thiopen-2-ylmethylene)-hydrazide |
0.043 |
Up |
FANCL |
S-(dimethylarsino)-3-mercapto-1,2-propyl dibenzoate |
0.013 |
Down |
FANCL |
NSC 726881 |
0.023 |
Up |
FANCL |
2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide |
0.021 |
Up |
FANCL |
Everolimus |
0.013 |
Up |
FANCL |
Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate |
0.008 |
Up |
FANCL |
NSC 735333 |
0.035 |
Up |
FANCL |
4-[(Z)-2-(5-nitro-2-furyl)ethenyl]-6-(4-phenylpiperazin-1-yl )-1,3,5-triazin-2-ylamine |
0.02 |
Down |
FANCL |
6-(10'-tert-BOC-aminododecyl)-5,6-dihydro-5,11-dioxo-11H-indeno-[1,2-c]isoquinoline |
0.029 |
Up |
FANCL |
NSC 740535 |
0.019 |
Up |
FANCL |
1-Acetyl-3-(4H-3,1-benzoxazin-2-yl)imidazolidin-2-thione |
0.049 |
Up |
Expression pattern: Sensitivity / Resistance
Total:13 Current:12
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:14
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:40
Total:3 Current:1
[First] [Prev]  Next Last 
|